41
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Analyzing Plasma HIV-1 RNA Measurements as Multiple Recurrent Events in Clinical Trials

, , , , , & show all
Pages 116-124 | Published online: 02 Feb 2015
 

Abstract

Primary endpoints based on levels of HIV-1 RNA are currently used to evaluate efficacy of antiretroviral therapy in AIDS/HIV clinical trials. These endpoints, however, are generally based on few HIV-1 RNA measurements. More specifically, when the endpoint is the time to virologic failure (usually defined as two consecutive HIV-1 RNA levels above a threshold value), viral load measurements recorded after failure are simply ignored in the analysis. Instead of one virologic failure used in a classical survival analysis, we suggest that a failure be defined as any plasma HIV-1 RNA level above a predefined threshold value. This then becomes an analysis of multiple events of the same type, that is, recurrent virologic failures. Many survival models based on the Cox proportional hazards model have been proposed to handle multiple event data. The two distinct classes of models (marginal and conditional) answer two distinct types of clinical question and should be considered as complementary rather than competing models. We applied the different models to data from a clinical trial in HIV-1-infected patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.